Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01349361
NCT01349361UnknownPhase 2

Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

Bispebjerg Hospital2 sites in 1 countryStarted: March 2011Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Locations
2
Primary Endpoint
complete disappearance of the BCC
Study OverviewEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •superficial BCC

Exclusion Criteria

  • •Immunosuppression

Outcomes

Primary Outcomes

complete disappearance of the BCC

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Photodynamic Therapy for Basal Cell Carcinoma of the Eyelid and Periocular Skin with methyl aminolevulinate - PDT for periocular BCCPeriocular basal cell carcinomaMedDRA version: 9.1Level: LLTClassification code 10004146Term: Basal cell carcinomaMedDRA version: 9.1Level: LLTClassification code 10004148Term: Basal cell carcinoma excision
EUCTR2007-004085-41-GBThe Royal Wolverhampton Hospitals NHS Trust15
Active, not recruiting
Phase 1
Optimized photodynamic therapy for skin cancerMedDRA version: 19.0Level: PTClassification code 10004146Term: Basal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Basal cell carcinoma
EUCTR2016-002508-16-DKDepartment of Dermatology D92, Bispebjerg Hospital50
Recruiting
Phase 1
RPhotobiomodulation therapy as an adjunct therapy in burn wound care
CTRI/2024/06/068433one
Completed
Not Applicable
Acute Effect of Photobiomodulation Therapy on Muscle Performance in Female Futsal PlayersMuscle PerformancePhotobiomodulation Therapy
NCT06562322Universidade Norte do Paraná15
Completed
Phase 2
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell CarcinomaLocally Advanced Basal Cell CarcinomaCutaneous MalignancySkin Cancer
NCT01835626Sue Yom24